Transcutaneous Spinal Cord Stimulation in Hereditary Spastic Paraplegias
Objective: To assess transcutaneous spinal cord stimulation (tSCS) as a treatment for hereditary spastic paraplegias (HSPs). Background: Hereditary spastic paraplegias (HSPs) are genetic disorders characterized…IncobotulinumtoxinA for the Treatment of Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy Evaluation of Lower Limb IncobotulinumtoxinA Efficacy (ELLIE)
Objective: To investigate the use of incobotulinumtoxinA in the treatment of lower limb spasticity in children and adolescents with cerebral palsy (CP). Background: Spasticity associated…Extracorporeal Shockwave Therapy (ESWT) for Neck Pain and Shoulder-Scapular Dyskinesis: An Objective Evaluation Study
Objective: The aim was to objectively evaluate the role of shoulder and scapular movement in neck pain and assess the efficacy of ESWT for treatment.…Continuous subcutaneous foslevodopa/foscarbidopa infusion therapy leads to a sustained reduction in dyskinesias in Parkinson’s disease
Objective: To assess the longitudinal effect of continuous subcutaneous foslevodopa/foscarbidopa infusion therapy on dyskinesias as measured by the Unified Dyskinesia Rating Scale (UDysRS) total score…Characteristics of IncobotulinumtoxinA Treatment for Limb Spasticity in a Real-World Setting: Dosing and Muscles Injected
Objective: This study described incobotulinumtoxinA doses and muscles injected in a real-world setting for patients with limb spasticity (LS). Background: IncobotulinumtoxinA is approved to treat…Goal Attainment and Ambulation With Increasing Doses of IncobotulinumtoxinA: A Post Hoc Analysis of the TOWER Study
Objective: To evaluate goal attainment and ambulation in a subpopulation of TOWER study patients treated with UK licensed doses of incobotulinumtoxinA (incoA) for injection cycles…Moderate-to-severe upper limb spasticity patterns in the elderly are improved following treatment with incobotulinumtoxinA: a pooled analysis
Objective: To compare upper limb spasticity (ULS) severity changes from baseline in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA (incoA)…Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: a pooled analysis
Objective: To compare changes from baseline in upper limb spasticity (ULS) severity in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA…Identifying and Managing Spasticity in Neurological Shoulder Dysfunction
Objective: To understand this discrepancy between diagnosis and treatment of spasticity in neurological shoulder dysfunction, we formed an expert panel to establish consensus and provide…Effectiveness of abobotulinumtoxinA in adults with lower limb spasticity: Results from the AboLiSh real world observational study
Objective: Assess longitudinal goal attainment with repeated injections of abobotulinumtoxinA (aboBoNT-A) in the lower-limb over 16-months in a routine clinical setting. Background: While the efficacy…
- 1
- 2
- 3
- …
- 7
- Next Page »